Developing medicine is a complicated process and as technology continues to evolve, so do the development processes. As such, we're going to continue to see a rise in the intersection of technology, biomanufacturing, and healthcare. On this episode, we sit down with Michelangelo Canzoneri, Ph.D., to discuss some of these trends, how he's leading an operation model transformation at Merck KGaA to develop preventative, precision and personalized medicine, and the 10 Key Digital Pillars that they're using to create this framework.

As mentioned, Michelangelo is speaking at this year's Virtual Biomanufacturing Summit on April 27-29. His topic is focused on "Biomanufacturing 4.0 - How to Get There". You can register here. 

Other topics include:

• Michelangelo's favorite books: Start With Why by Simon Sinek, Dead Poets Society by Nancy Kleinbaum, A Brief History of Time by Stephen Hawking, and Thinking Fast and Slow by Daniel Kahneman 
• The personal reason for why Michelangelo got started in the technology and biomanufacturing space 
• The most important qualities of leaders 
• Why he believes curiosity is one of the biggest skills and perspectives to have in life 
• How technology is driving data quality, connection, integration and more at Merck KGaA 
• What it means to build a digital continuum 
• The benefits of data modeling and digital twins 
• Why it's important to demystify digital and how to do it in tangible ways
• What to be excited for in the future of healthcare and technology 
• The importance of education and being a passionate leader throughout your career 

About Michelangelo: Michelangelo Canzoneri is a proven digital leader who is passionate about improving and enhancing the patient experience across the digital continuum. He has expertise in optimizing and transforming the operating model of healthcare and pharmaceutical businesses, while conceptualizing and creating new business models. He leads the digital transformation at the Healthcare business of Merck and is based in Germany. An expert in bioprocess engineering and bioprocess optimization, Michelangelo has fundamental experience with developing and industrializing scalable manufacturing processes from pre-clinic to clinical trials Phase III, including good manufacturing practices. He has created and implemented the vision for a Factory 4.0 and the Lab of the Future, including smart processes for manufacturing and formulation protocols, a platform for end to end innovation across technology domains, and seamlessly integrated digital analytics and intelligence operations. Michelangelo has successfully broken-down silos within R&D and manufacturing, saving billions of euros through new technologies, and efficiency improvements. As a leader in knowledge management, Michelangelo is paving the way toward preventive, precision and personalized medicine through the integration of science and technology with digitization. Michelangelo obtained his PhD in Bioprocess Engineering at the University of Bielefeld, Germany and before joining Merck, he held positions at Kourion Therapeutics AG in quality control and Sanofi, where he worked transversally in R&D, Industrial Affairs, Technology and Innovation, and Digital Transformation. Michelangelo is a strong supporter of education and training students, and bridging academics and industry. He is a Professor at Frankfurt University of Applied Sciences, Germany and a Guest Lecturer at Massachusetts Institute of Technology, USA. Michelangelo holds several patents, including a micro bioreactor developed together with MIT. Michelangelo is fluent in German, Italian and English. 

You can view our first events of 2021 here: 

• The Virtual American Biomanufacturing Summit on April 27-29, 2021
• The Virtual American Supply Chain Summit on May 11-13, 2021
• The Virtual American CIO & IT Summit on May 25-27, 2021

To find out more about our summits and Generis Group, you can head to generisgp.com/events.

The brewery and beverage industries have been undergoing reinvention as consumer demands and sustainability practices have changed over the last several years. That makes for a lot of challenges but also a ton of excitement and opportunity. On this episode, we sit down with Chantalle Butler, Chief Financial Officer of Molson Coors Canada and discuss her rise through the ranks of CPG and finance, leading teams, and imposter syndrome.

Other topics include: 

• How routine helps her both in her professional and personal life 
• Why Jim Collins' "Good to Great" is her favourite book on leadership 
• What excites her the most about the CPG and brewery industry right now 
• How having cross-functional experience in retail and auditing has helped her in her career 
• What leaders can do to actively guide through reinvention
• What it means to be the first woman to be Chair of The Beer Store
• How she managed her imposter syndrome in both her personal and work life
• Why she didn't view being a woman as a barrier in her career
• The most important leadership quality that has served her in her career 

About Chantalle: With more than 20 years in the Consumer Packaged Goods and food production industry as a finance executive, Chantalle forged her way up through mostly male-dominant businesses, never hindered nor limited by notions of positions a female typically occupies. With her newly added scope as Chair of the TBS Board of Directors, she and her 15-member Board are entrusted to understand and act upon consumer demand from product innovation through to shopper experience. Her commitment to reinforcing environmental stewardship and social responsibility coupled with her financial vision will also drive renewed priorities for the retailer. 

You can view our first events of 2021 here: 

• The Virtual American Biomanufacturing Summit on April 27-29, 2021
• The Virtual American Supply Chain Summit on May 11-13, 2021
• The Virtual American CIO & IT Summit on May 25-27, 2021

To find out more about our summits and Generis Group, you can head to generisgp.com/events.

From government policies to consumer demands to emphasizing the UN Sustainable Development Goals, building sustainability practices into your business is in high demand. With an emphasis on the concept of people, planet and profit and the inevitable timing of climate change, sustainability is a hot topic with many organizations investing more heavily in this department. 

On this episode, we sat down with Mary Draves, Chief Sustainability Officer and VP of Environmental Health and Safety at Dow to talk about the work that Dow has been doing in sustainability and the importance of collaboration in turning your goals into action.

In this episode, topics include: 

• How Mary's love for sustainability started on her family's dairy farm 
• Dow's long history of sustainability, reducing waste, reducing energy and promoting circularity 
• Making sustainability a part of your business practices 
• Infusing a culture of sustainability throughout the organization with a top-down approach 
• Setting your targets and working to meet them through collaboration 
• Making the right financial and collaboration decisions for tangible action
• Creating shared values with your collaborators and knowing when to partner with other organizations
• How future generations will continue to push sustainability and hold companies accountable

You can find out more about Dow's Sustainability Goal's in their 2019 Report.

You can view our first events of 2021 here: 

• The Virtual American Biomanufacturing Summit on April 27-29, 2021 
• The Virtual American Supply Chain Summit on May 11-13, 2021 
• The Virtual American CIO & IT Summit on May 25-27, 2021 

To find out more about our summits and Generis Group, you can head to generisgp.com/events.